The earnings call highlighted significant growth in cash revenue from new tenants and successful refinancing activities, alongside strong performance in both international and US portfolios. However, challenges persist due to net impairments, unresolved Prospect bankruptcy issues, and specific tenant difficulties, which temper the overall positive outlook.

Company Guidance

During the Medical Properties Trust Second Quarter 2025 Earnings Conference Call, the company provided several key metrics and guidance updates. The firm reported an increase in rental income from new tenants, with cash revenue from these properties rising from approximately $3.4 million in the first quarter to $11 million in the second quarter, and it is expected to reach approximately $17 million by the third quarter. The company aims to achieve total annualized cash rent of more than $1 billion by the end of 2026. In its European portfolio, a successful EUR 702 million refinancing transaction was completed at a 5.1% fixed rate. For the second quarter of 2025, Medical Properties Trust reported a normalized FFO of $0.14 per share. Operationally, tenants are reporting increasing EBITDARM coverage ratios, with some U.S. operators seeing EBITDARM coverage of 2.3x to 2.8x. The company has been actively managing its balance sheet, focusing on refinancing and maintaining financial flexibility, with plans to execute further asset sales totaling more than $100 million by year-end.

Increase in Cash Revenue from New Tenants

Rental income from new tenants increased from $3.4 million in the first quarter to $11 million in the second quarter, with expectations to reach approximately $17 million by the third quarter.

Successful European Portfolio Refinancing

A EUR 702 million refinancing transaction in Germany was completed at a 5.1% fixed rate, demonstrating strong investor appetite for healthcare infrastructure in Europe.

International Portfolio Growth

Circle in the UK is investing in robotics and AI, Priory in the UK has maintained steady performance, and Median in Germany reported excellent year-over-year revenue and earning improvements.

US Portfolio Performance

Earnest Health's EBITDARM coverage increased to 2.3x, LifePoint Health reported strong top line revenue growth, and Surgery Partners delivered impressive performance with EBITDARM coverage of approximately 7x.

Stabilized Portfolio and Cash Flow Outlook

With steady contributions from the stabilized portfolio and ramping new operators, the company expects to reach total annualized cash rent of more than $1 billion by year-end 2026.

Medical Properties (MPW) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MPW Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	0.01 / -	-1.34	―	―	―
Jul 31, 2025	2025 (Q2)	>-0.01 / -0.16	-0.54	70.37% (+0.38)
May 01, 2025	2025 (Q1)	0.01 / -0.20	-1.23	83.74% (+1.03)	―
Feb 27, 2025	2024 (Q4)	-0.06 / -0.69	-1.11	37.84% (+0.42)	―
Nov 07, 2024	2024 (Q3)	0.02 / -1.34	0.19	-805.26% (-1.53)	―
Aug 08, 2024	2024 (Q2)	0.04 / -0.54	-0.07	-671.43% (-0.47)	―
May 09, 2024	2024 (Q1)	0.09 / -1.23	0.05	-2560.00% (-1.28)	―
Feb 21, 2024	2023 (Q4)	0.15 / -1.11	-0.24	-362.50% (-0.87)	―
Oct 26, 2023	2023 (Q3)	0.19 / 0.19	0.37	-48.65% (-0.18)
Aug 08, 2023	2023 (Q2)	0.22 / -0.07	0.32	-121.88% (-0.39)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MPW Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$4.13	$4.12	-0.24%
May 01, 2025	$5.42	$5.05	-6.83%
Feb 27, 2025	$4.62	$5.41	+17.10%
Nov 07, 2024	$4.36	$4.31	-1.15%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.